469.20001 EUR
6.4
1.35%
Last update Dec 16, 9:55 PM CET
Main market
Day range
463.5
471.10001
Previous close
475.60001
Open
471.10001
Access this stock data via API
Subscribe
Madrigal Pharmaceuticals, Inc.
469.20
6.40
1.35%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 244.8M 181.4M 117.0M 88.1M
Cost of revenue 15.4M 7.7M 3.8M 2.9M
Gross profit 229.4M 173.6M 113.1M 85.1M
Operating expense
Research & development 148.3M 46.1M 37.6M 21.9M
Selling general and admin 178.2M 167.8M 143.1M 120.4M
Other operating expenses
Operating income -97.1M -40.2M -67.6M -57.1M
Non operating interest income
Income 8.8M 7.0M 8.0M 9.4M
Expense 6.4M 2.8M 2.8M 3.0M
Other income expense -2.6M -35.8K
Pretax income -97.3M -36.0M -62.4M -50.6M
Tax provision
Net income -97.3M -36.0M -62.4M -50.6M
Basic EPS -1.9 -3.3 -2.7
Diluted EPS -1.9 -3.3 -2.7
Basic average shares 18.9M 18.8M 18.7M
Diluted average shares 18.9M 18.8M 18.7M
EBITDA -88.3M -32.9M -59.3M -47.3M
Net income from continuing op. -97.3M -36.0M -62.4M -50.6M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 2 hours 34 minutes

19:25
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).